K R Patel1, V Singam1, P P Vakharia1, R Chopra1, R Sacotte1, N Patel1, S Immaneni1, R Kantor1, D Y Hsu1, J I Silverberg1,2,3,4. 1. Department of Dermatology, Feinberg School of Medicine at Northwestern University, Chicago, IL, U.S.A. 2. Department of Medical Social Sciences, Feinberg School of Medicine at Northwestern University, Chicago, IL, U.S.A. 3. Department of Preventive Medicine, Feinberg School of Medicine at Northwestern University, Chicago, IL, U.S.A. 4. Northwestern Medicine Multidisciplinary Eczema Center, Chicago, IL, U.S.A.
Abstract
BACKGROUND: Standardized quality-of-life (QoL) assessments can provide important and clinically relevant information. There is currently a lack of standardization in QoL assessments used in atopic dermatitis (AD). OBJECTIVES: To determine the content validity, construct validity, internal consistency, differential reporting, responsiveness, floor or ceiling effects and feasibility of the Dermatology Life Quality Index (DLQI), Itchy Quality of Life (ItchyQoL) and 5-dimensions (5-D) itch scales for assessing burden of AD in adults and to compare their performance. METHODS: Self-administered questionnaires and skin examination were performed in 340 adults with AD in a dermatology practice setting. RESULTS: DLQI, ItchyQoL and 5-D all had good content validity. DLQI, mean ItchyQoL and 5-D itch all had strong correlations with frequency of AD symptoms (Patient-Oriented Eczema Measure) and intensity of itch (numerical rating scale for itch), and moderate correlations with AD severity (Eczema Area and Severity Index and Scoring Atopic Dermatitis) (Spearman correlations, P < 0·001 for all). DLQI and 5-D itch showed good internal consistency (Cronbach's alpha = 0·89 and 0·84), although ItchyQoL appeared to have several redundant items (alpha = 0·96). Uniform and nonuniform differential item functioning by age, sex and/or race/ethnicity was found for multiple items in DLQI, ItchyQoL and 5-D itch. DLQI, ItchyQoL and 5-D itch scores all demonstrated responsiveness, although ItchyQoL demonstrated the greatest responsiveness. There were no floor or ceiling effects for total scores. The median times for completion of DLQI, ItchyQoL and 5-D itch were 2 min. CONCLUSIONS: The DLQI, ItchyQoL and 5-D itch scales all showed good content and construct validity, and responsiveness in the assessment of AD in adults, and were feasible for use in clinical trials and practice.
BACKGROUND: Standardized quality-of-life (QoL) assessments can provide important and clinically relevant information. There is currently a lack of standardization in QoL assessments used in atopic dermatitis (AD). OBJECTIVES: To determine the content validity, construct validity, internal consistency, differential reporting, responsiveness, floor or ceiling effects and feasibility of the Dermatology Life Quality Index (DLQI), Itchy Quality of Life (ItchyQoL) and 5-dimensions (5-D) itch scales for assessing burden of AD in adults and to compare their performance. METHODS: Self-administered questionnaires and skin examination were performed in 340 adults with AD in a dermatology practice setting. RESULTS: DLQI, ItchyQoL and 5-D all had good content validity. DLQI, mean ItchyQoL and 5-Ditch all had strong correlations with frequency of AD symptoms (Patient-Oriented Eczema Measure) and intensity of itch (numerical rating scale for itch), and moderate correlations with AD severity (Eczema Area and Severity Index and Scoring Atopic Dermatitis) (Spearman correlations, P < 0·001 for all). DLQI and 5-Ditch showed good internal consistency (Cronbach's alpha = 0·89 and 0·84), although ItchyQoL appeared to have several redundant items (alpha = 0·96). Uniform and nonuniform differential item functioning by age, sex and/or race/ethnicity was found for multiple items in DLQI, ItchyQoL and 5-Ditch. DLQI, ItchyQoL and 5-Ditch scores all demonstrated responsiveness, although ItchyQoL demonstrated the greatest responsiveness. There were no floor or ceiling effects for total scores. The median times for completion of DLQI, ItchyQoL and 5-Ditch were 2 min. CONCLUSIONS: The DLQI, ItchyQoL and 5-Ditch scales all showed good content and construct validity, and responsiveness in the assessment of AD in adults, and were feasible for use in clinical trials and practice.
Authors: L A A Gerbens; C A C Prinsen; J R Chalmers; A M Drucker; L B von Kobyletzki; J Limpens; H Nankervis; Å Svensson; C B Terwee; J Zhang; C J Apfelbacher; P I Spuls Journal: Allergy Date: 2016-07-13 Impact factor: 13.146
Authors: Jonathan I Silverberg; Robert W Kantor; Prarthana Dalal; Catherine Hickey; Sara Shaunfield; Karen Kaiser; Jin-Shei Lai; David Cella Journal: Am J Clin Dermatol Date: 2018-10 Impact factor: 7.403
Authors: Lawrence F Eichenfield; Wynnis L Tom; Sarah L Chamlin; Steven R Feldman; Jon M Hanifin; Eric L Simpson; Timothy G Berger; James N Bergman; David E Cohen; Kevin D Cooper; Kelly M Cordoro; Dawn M Davis; Alfons Krol; David J Margolis; Amy S Paller; Kathryn Schwarzenberger; Robert A Silverman; Hywel C Williams; Craig A Elmets; Julie Block; Christopher G Harrod; Wendy Smith Begolka; Robert Sidbury Journal: J Am Acad Dermatol Date: 2013-11-27 Impact factor: 11.527
Authors: Eric L Simpson; Marjolein Bruin-Weller; Carsten Flohr; Michael R Ardern-Jones; Sebastien Barbarot; Mette Deleuran; Thomas Bieber; Christian Vestergaard; Sara J Brown; Michael J Cork; Aaron M Drucker; Lawrence F Eichenfield; Regina Foelster-Holst; Emma Guttman-Yassky; Audrey Nosbaum; Nick J Reynolds; Jonathan I Silverberg; Jochen Schmitt; Marieke M B Seyger; Phyllis I Spuls; Jean-Francois Stalder; John C Su; Roberto Takaoka; Claudia Traidl-Hoffmann; Jacob P Thyssen; Jorien van der Schaft; Andreas Wollenberg; Alan D Irvine; Amy S Paller Journal: J Am Acad Dermatol Date: 2017-08-10 Impact factor: 11.527
Authors: C B Terwee; C A C Prinsen; A Chiarotto; M J Westerman; D L Patrick; J Alonso; L M Bouter; H C W de Vet; L B Mokkink Journal: Qual Life Res Date: 2018-03-17 Impact factor: 4.147
Authors: Sherief R Janmohamed; Eran C Gwillim; Muhammad Yousaf; Kevin R Patel; Jonathan I Silverberg Journal: Arch Dermatol Res Date: 2020-10-27 Impact factor: 3.017
Authors: F M Vermeulen; L A A Gerbens; A L Bosma; C J Apfelbacher; A D Irvine; B W M Arents; S Barbarot; M Deleuran; L F Eichenfield; A Manca; J Schmitt; C Vestergaard; D Wall; S Weidinger; M A Middelkamp-Hup; P I Spuls; C Flohr Journal: Br J Dermatol Date: 2019-06-23 Impact factor: 9.302
Authors: J I Silverberg; D Lei; M Yousaf; S R Janmohamed; P P Vakharia; R Chopra; R Chavda; S Gabriel; K R Patel; V Singam; R Kantor; D Y Hsu Journal: Br J Dermatol Date: 2020-09-21 Impact factor: 9.302
Authors: J I Silverberg; D Lei; M Yousaf; S R Janmohamed; P P Vakharia; R Chopra; R Chavda; S Gabriel; K R Patel; V Singam; R Kantor; D Y Hsu Journal: J Eur Acad Dermatol Venereol Date: 2020-09-01 Impact factor: 6.166
Authors: Trisha Kaundinya; Uros Rakita; Armaan Guraya; Donna Maria Abboud; Emily Croce; Jacob P Thyssen; Andrew Alexis; Jonathan I Silverberg Journal: J Invest Dermatol Date: 2021-08-02 Impact factor: 8.551